Free Trial

Sera Prognostics (SERA) Stock Price, News & Analysis

Sera Prognostics logo
$2.00 -0.02 (-0.75%)
As of 02:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Sera Prognostics Stock (NASDAQ:SERA)

Advanced

Key Stats

Today's Range
$1.98
▼
$2.14
50-Day Range
$1.93
▼
$2.19
52-Week Range
$1.56
▼
$3.85
Volume
9,399 shs
Average Volume
44,616 shs
Market Capitalization
$78.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Moderate Buy

Company Overview

Sera Prognostics, Inc. is a women’s health company focused on identifying pregnancy risks through blood-based testing and biomarker research. The company develops diagnostic products intended to help healthcare providers assess pregnancy outcomes and support individualized care.

Its lead product, the PreTRM test, analyzes proteins in a pregnant patient’s blood to estimate the risk of spontaneous preterm birth. The company has developed the test for use by healthcare providers in the United States and continues to study its potential role in pregnancy care.

AI Generated. May Contain Errors.

Sera Prognostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

SERA MarketRank™: 
3.046015117355 of 5 stars

Sera Prognostics scored higher than 61% of companies evaluated by MarketBeat, and ranked 362nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sera Prognostics has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Sera Prognostics has a consensus price target of $5.50, representing about 164.9% upside from its current price of $2.08.

  • Amount of Analyst Coverage

    Sera Prognostics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Sera Prognostics' stock forecast and price target.
  • Earnings Growth

    Earnings for Sera Prognostics are expected to grow in the coming year, from ($0.62) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sera Prognostics is -3.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sera Prognostics is -3.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sera Prognostics has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.63% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 9.12.
  • Change versus previous month

    Short interest in Sera Prognostics has recently decreased by 1.33%, indicating that investor sentiment is improving.
  • Dividend Yield

    Sera Prognostics does not currently pay a dividend.

  • Dividend Growth

    Sera Prognostics does not have a long track record of dividend growth.

  • News Sentiment

    Sera Prognostics has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Sera Prognostics this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Sera Prognostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $79,563.00 in company stock.

  • Percentage Held by Insiders

    11.30% of the stock of Sera Prognostics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    54.64% of the stock of Sera Prognostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sera Prognostics' insider trading history.
Receive SERA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SERA Stock News Headlines

Sera Prognostics (SERA) Q3 2026 Earnings Call Transcript
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel
See More Headlines

SERA Stock Analysis - Frequently Asked Questions

Sera Prognostics' stock was trading at $2.95 at the beginning of 2026. Since then, SERA stock has decreased by 29.6% and is now trading at $2.0760.

Sera Prognostics, Inc. (NASDAQ:SERA) released its earnings results on Wednesday, November, 4th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by $0.02. The company earned $42 thousand during the quarter, compared to analysts' expectations of $75 thousand. Sera Prognostics had a negative net margin of 34,866.67% and a negative trailing twelve-month return on equity of 52.54%.
Read the conference call transcript
.

Sera Prognostics (SERA) raised $75 million in an IPO on Wednesday, July 14th 2021. The company issued 4,687,500 shares at $15.00-$17.00 per share.

Top institutional shareholders of Sera Prognostics include Sanders Morris Harris LLC (0.80%), State Street Corp (0.32%) and Empowered Funds LLC (0.13%). Insiders that own company stock include Zhenya Lindgardt, Austin Aerts, Paul Kearney, Benjamin Jackson, John J Boniface, Tiffany Eul Davis Inglis, Robert Gardner Harrison, Dyaarl Lee Jr Anderson, Mansoor Raza Mirza, Sandra Aj Lawrence and Joshua Phillips.
View institutional ownership trends
.

Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sera Prognostics investors own include Aterian (ATER), Erasca (ERAS), 9 Meters Biopharma (NMTR), Orion Energy Systems (OESX), Rani Therapeutics (RANI), RxSight (RXST) and ONE Group Hospitality (STKS).

Company Calendar

Last Earnings
11/04/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SERA
CIK
1534969
Fax
N/A
Employees
72
Year Founded
2008

Price Target and Rating

High Price Target
$6.00
Low Price Target
$5.00
Potential Upside/Downside
+177.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.93 million
Net Margins
-34,866.67%
Pretax Margin
-34,866.67%
Return on Equity
-52.54%
Return on Assets
-36.97%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.88
Quick Ratio
1.88

Sales & Book Value

Annual Sales
$96 thousand
Price / Sales
813.64
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.94 per share
Price / Book
1.02

Miscellaneous

Outstanding Shares
39,449,000
Free Float
35,276,000
Market Cap
$78.11 million
Optionable
Optionable
Beta
1.14

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NASDAQ:SERA) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners